Furthermore, plasma levels of C5a and the complement activation product C5b-9 were found to be significantly elevated in patients with CAPS and those suffering from refractory thrombotic APS [91,92]. The gene discussed is C5; the disease is cryopyrin-associated periodic syndrome.